Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Article in English | IMSEAR | ID: sea-171157

ABSTRACT

Femoral lengthening using Ilizarov technique was performed in ten patients comprising of 6 females and 4 males in an age group of 10-19 years with an average shortening of 6.8 cms. The etiology of shortening was post-infective in 8 patients and post-traumatic in two patients. The desired length was achieved in six patients and in four patients the final limb length discrepancy ranged between 1 to 3 cms. The total duration of external fixation ranged from 24 weeks to 90 weeks with an average healing index of 6.23 weeks/cm. There were 10 problems and 2 true complications. Temporary decrease in knee range of motion was a common difficulty encountered during lengthening. Results were rated as excellent in five, good in two, fair in two and poor in one patient. Key words Ilizarov Technique, Femoral lengthening Introduction The

2.
Article in English | IMSEAR | ID: sea-171026

ABSTRACT

Seven children (12 to 15 years) having madelung's deformity were considered for the study. All the children complained of aesthetic deformity with functional difficulties with their daily life activities. Ilizarov's technique by lengthening and re-axation of distal extremity of the radius was used as therapeutic modality. The short term follow up provides satisfactory results. However. long term study is needed to say with certainty that the technique prevent subsequent secondary osteo anthritis.

3.
Article in English | IMSEAR | ID: sea-171002

ABSTRACT

The Imrmmoglobulin levels (IgA, IgM, IgG) in 53 patients suffering from acute hematogenous osteomyelitis were compared with 32 controls of comparable age and sex. IgA levels were significantly decreased in stage I and stage II, as compared with controls, while IgM levels were increased in stage I compared to control and in stage II there was decline in IgM levels. IgG levels showed an increase in stage I and a further increase in stage II as compared to control group, thereby sharing an increase in IgG levels with improvement in disease conditions.

SELECTION OF CITATIONS
SEARCH DETAIL